Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

On-Eye Optical Quality of Lotrafilcon B Lenses Over 12 Hours

Phase 4

Completed

Conditions: Myopia
Hyperopia

Interventions: Device: Lotrafilcon B
Device: lotrafilcon B with Hydraluxe

First Posted Date: 2019-03-19

Last Posted Date: 2020-03-10

Lead Sponsor: Indiana University

Target Recruit Count: 24

Registration Number: NCT03881670

Locations: 🇺🇸
Indiana University Clinical Optics Research Lab, Bloomington, Indiana, United States

Home-based SSP on Individuals With PWS

Not Applicable

Terminated

Conditions: Prader-Willi Syndrome

Interventions: Behavioral: Safe and Sound Protocol

First Posted Date: 2019-03-12

Last Posted Date: 2022-03-07

Lead Sponsor: Indiana University

Target Recruit Count: 10

Registration Number: NCT03871751

Locations: 🇺🇸
Integrated Listening Systems, Aurora, Colorado, United States

Non-Invasive Cardiac Output Monitor in Children

Completed

Conditions: Cardiac Output, Low
Pediatric

First Posted Date: 2019-03-11

Last Posted Date: 2020-07-30

Lead Sponsor: Indiana University

Target Recruit Count: 50

Registration Number: NCT03869606

Locations: 🇺🇸
Riley Hospital for Children, Indianapolis, Indiana, United States

Association Between Lactase Deficiency, and the Small Intestinal Microbiome in Adults.

Completed

Conditions: Lactose Intolerance

First Posted Date: 2019-03-01

Last Posted Date: 2024-03-06

Lead Sponsor: Indiana University

Target Recruit Count: 37

Registration Number: NCT03860051

Locations: 🇺🇸
Indiana University Hospital, Indianapolis, Indiana, United States

Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures

Phase 3

Completed

Conditions: Pain, Postoperative
Thoracic
Acute Pain

Interventions: Drug: Liposomal Bupivacaine
Drug: Bupivacaine, 0.5%
Drug: Bupivacaine, 0.25%

First Posted Date: 2019-03-01

Last Posted Date: 2023-08-16

Lead Sponsor: Indiana University

Target Recruit Count: 125

Registration Number: NCT03859635

Locations: 🇺🇸
Indiana University Hospital, Indianapolis, Indiana, United States

Testing a Novel Community-based Occupational Therapy Model

Not Applicable

Completed

Conditions: Mental Disorders, Severe

Interventions: Behavioral: Case management; psychological services
Behavioral: Occupational Therapy

First Posted Date: 2019-02-27

Last Posted Date: 2020-02-11

Lead Sponsor: Indiana University

Target Recruit Count: 27

Registration Number: NCT03855761

Locations: 🇺🇸
Eskenazi - Midtown Community Mental Health (James Wright Center), Indianapolis, Indiana, United States

Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery

Completed

Conditions: Monoclonal Gammopathy of Undetermined Significance

First Posted Date: 2019-02-27

Last Posted Date: 2024-12-18

Lead Sponsor: Indiana University

Target Recruit Count: 209

Registration Number: NCT03855878

Locations: 🇺🇸
Indiana University Simon Cancer Center, Indianapolis, Indiana, United States

Alcoholic Hepatitis Network Observational Study

Recruiting

Conditions: Alcoholic Hepatitis

First Posted Date: 2019-02-22

Last Posted Date: 2024-02-20

Lead Sponsor: Indiana University

Target Recruit Count: 1260

Registration Number: NCT03850899

Locations: 🇺🇸
IU School of Medicine, Indianapolis, Indiana, United States
🇺🇸
University of Louisville, Louisville, Kentucky, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 6 locations

Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections

Not Applicable

Completed

Conditions: Musculoskeletal Infection
Osteomyelitis
Acute Hematogenous Osteomyelitis
Septic Arthritis
Pyomyositis

Interventions: Diagnostic Test: Karius Test

First Posted Date: 2019-02-20

Last Posted Date: 2023-12-01

Lead Sponsor: Indiana University

Target Recruit Count: 38

Registration Number: NCT03846804

Locations: 🇺🇸
Riley Hospital for Children, Indianapolis, Indiana, United States

Reducing the Risk of Drug-Induced QT Interval Lengthening in Women

Phase 4

Completed

Conditions: Long QT Syndrome
Abnormalities, Drug-Induced

Interventions: Drug: Progesterone
Drug: Ibutilide

First Posted Date: 2019-02-08

Last Posted Date: 2024-05-31

Lead Sponsor: Indiana University

Target Recruit Count: 16

Registration Number: NCT03834883

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy